A risk reduction strategy to prevent maternal deaths associated with unsafe abortion

International Journal of Gynecology and Obstetrics

Volumn 95, Issue 2, 2006, Pages 221-226

  Briozzo, L ^a   Vidiella, G ^a   Rodriguez F ^a   Gorgoroso, M ^a   Faundes A ^b   Pons, J E ^a  

^a DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Maternal mortality; Misoprostol; Risk reduction strategy; Unsafe abortion; Uruguay

Indexed keywords

MISOPROSTOL;

ABORTION; ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; INDUCED ABORTION; MAJOR CLINICAL STUDY; MATERNAL MORTALITY; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; RISK REDUCTION; URUGUAY;

EID: 33750376974     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2006.07.013     Document Type: Article

References (7)

1. Briozzo L., Vidiella G., Vidarte B., Ferreiro G., Cuadro J.C., and Pons J.E. Induced abortion under unsafe conditions. Health emergencies and maternal mortality in Uruguay. The current situation and medical initiatives for safe motherhood. Revista Medical de Uruguay 18 1 (2002) 4-14
2. Briozzo L., Rodriguez F., Leon I., Vidiella G., Ferreiro G., and Pons J.E. Unsafe abortion in Uruguay. Int J Gynecol Obstet 85 1 (2004) 70-73
3. Stephenson P., Wagner M., Badea M., and Serbanescu F. Commentary: the public health consequences of restricted induced abortion. Lessons from Romania. Am J Publ Health 82 10 (1992) 1328-1331
4. Tietze C., Pakter J., and Berger G.S. Mortality with legal abortion in New York City, 1970-1972. J Am Med Assoc 225 5 (1973) 507-509
5. Hahn R.A., Onorato I.M., Jones T.S., and Dougherty J. Prevalence of HIV infection among intravenous drug users in the United States. JAMA 261 18 (1989) 2677-2684
6. Needle R.H., Coyle S.L., Normand J., Lambert E., and Cesari H. HIV prevention with drug-using populations-current status and future prospects: introduction and overview. Public Health Rep 113 Suppl. 1 (1998) 4-17
7. Schenker J.G., and Cain J.M. FIGO Committee for the Ethical Aspects of Human Reproduction and Women's Health. Int J Gynecol Obstet 64 (1999) 317-322